{"count": 5, "results": [{"_id": "34582339", "pmid": 34582339, "title": "Is metformin use associated with changes in urinary parameters in stone formers?", "journal": "Can Urol Assoc J", "authors": ["Rosen DC", "Bamberger JN", "Kaplan-Marans E", "Paranjpe I", "Kapoor A", "Gallante B", "Atashsokhan DJ", "Zampini AM", "Khusid JA", "Atallah WM", "Gupta M"], "date": "2022-02-01T00:00:00Z", "doi": "10.5489/cuaj.7344", "meta_date_publication": "2022 Feb", "meta_volume": "16", "meta_issue": "2", "meta_pages": "E88-E93", "score": 50265.965, "text_hl": "The relationship between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>DISEASE_Nephrolithiasis</m> @DISEASE_MESH:D053040 @@@nephrolithiasis@@@ formation remains unclear, as studies have demonstrated conflicting results. ", "citations": {"NLM": "Rosen DC, Bamberger JN, Kaplan-Marans E, Paranjpe I, Kapoor A, Gallante B, Atashsokhan DJ, Zampini AM, Khusid JA, Atallah WM, Gupta M. Is metformin use associated with changes in urinary parameters in stone formers? Can Urol Assoc J. 2022 Feb;16(2):E88-E93. PMID: 34582339", "BibTeX": "@article{34582339, title={Is metformin use associated with changes in urinary parameters in stone formers?}, author={Rosen DC and Bamberger JN and Kaplan-Marans E and Paranjpe I and Kapoor A and Gallante B and Atashsokhan DJ and Zampini AM and Khusid JA and Atallah WM and Gupta M}, journal={Can Urol Assoc J}, volume={16}, number={2}, pages={E88-E93}}"}}, {"_id": "36914110", "pmid": 36914110, "title": "Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stone.", "journal": "Arch Biochem Biophys", "authors": ["Zhang X", "Liang F", "Li T", "Jiang Y", "Ren F"], "date": "2023-05-01T00:00:00Z", "doi": "10.1016/j.abb.2023.109568", "meta_date_publication": "2023 May 1", "meta_volume": "739", "meta_issue": "", "meta_pages": "109568", "score": 50263.92, "text_hl": "Deposition of @CHEMICAL_Calcium_Oxalate @CHEMICAL_MESH:D002129 @@@calcium oxalate@@@ (@CHEMICAL_Calcium_Oxalate @CHEMICAL_MESH:D002129 @@@CaOx@@@) crystals and @DISEASE_Mitochondrial_Diseases @DISEASE_MESH:D028361 @@@oxidative@@@ stress-induced injury of renal tubular epithelial cell are the primary pathogenic factors of @<m>DISEASE_Nephrolithiasis</m> @DISEASE_MESH:D053040 @@@nephrolithiasis@@@. In this study we investigated the beneficial effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin hydrochloride@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MH@@@) against @<m>DISEASE_Nephrolithiasis</m> @DISEASE_MESH:D053040 @@@nephrolithiasis@@@ and explored the underlying molecular mechanism. ", "citations": {"NLM": "Zhang X, Liang F, Li T, Jiang Y, Ren F. Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stone. Arch Biochem Biophys. 2023 May 1;739():109568. PMID: 36914110", "BibTeX": "@article{36914110, title={Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stone.}, author={Zhang X and Liang F and Li T and Jiang Y and Ren F}, journal={Arch Biochem Biophys}, volume={739}, pages={109568}}"}}, {"_id": "36567309", "pmid": 36567309, "title": "Ecofriendly appraisal of stability-indicating high-performance chromatographic assay of canagliflozin and metformin with their toxic impurities; in silico toxicity prediction.", "journal": "J Sep Sci", "authors": ["Emam RA", "Emam AA"], "date": "2022-12-25T00:00:00Z", "doi": "10.1002/jssc.202200754", "meta_date_publication": "2022 Dec 25", "meta_volume": "", "meta_issue": "", "meta_pages": "e2200754", "score": 50248.625, "text_hl": "@CHEMICAL_Canagliflozin @CHEMICAL_MESH:D000068896 @@@Canagliflozin@@@ has one reported major degradation product, also @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin hydrochloride@@@ has one reported major degradation product, @CHEMICAL_dicyandiamido @CHEMICAL_MESH:C004711 @@@cyanoguanidine@@@, and has a potential toxic impurity, @CHEMICAL_melamine @CHEMICAL_MESH:C011907 @@@melamine@@@, that is reported to cause @DISEASE_Crystalluria @DISEASE_MESH:D000092162 @@@crystalluria@@@ that causes @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@chronic kidney inflammation@@@ and @<m>DISEASE_Nephrolithiasis</m> @DISEASE_MESH:D053040 @@@nephrolithiasis@@@ leading to a @DISEASE_Renal_Insufficiency @DISEASE_MESH:D051437 @@@renal failure@@@. ", "citations": {"NLM": "Emam RA, Emam AA. Ecofriendly appraisal of stability-indicating high-performance chromatographic assay of canagliflozin and metformin with their toxic impurities; in silico toxicity prediction. J Sep Sci. 2022 Dec 25;():e2200754. PMID: 36567309", "BibTeX": "@article{36567309, title={Ecofriendly appraisal of stability-indicating high-performance chromatographic assay of canagliflozin and metformin with their toxic impurities; in silico toxicity prediction.}, author={Emam RA and Emam AA}, journal={J Sep Sci}, pages={e2200754}}"}}, {"_id": "30720053", "pmid": 30720053, "pmcid": "PMC6414169", "title": "Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo", "journal": "Int J Mol Med", "authors": ["Yang X", "Yang T", "Li J", "Yang R", "Qi S", "Zhao Y", "Li L", "Li J", "Zhang X", "Yang K", "Xu Y", "Liu C"], "date": "2019-04-01T00:00:00Z", "doi": "10.3892/ijmm.2019.4084", "meta_date_publication": "2019 Apr", "meta_volume": "43", "meta_issue": "4", "meta_pages": "1611-1622", "score": 50069.414, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ prevents @<m>DISEASE_Nephrolithiasis</m> @DISEASE_MESH:D053040 @@@nephrolithiasis@@@ formation by inhibiting the expression of @GENE_SPP1 @GENE_478471 @@@OPN@@@ and MCP-1 in vitro and in vivo", "citations": {"NLM": "Yang X, Yang T, Li J, Yang R, Qi S, Zhao Y, Li L, Li J, Zhang X, Yang K, Xu Y, Liu C. Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo Int J Mol Med. 2019 Apr;43(4):1611-1622. PMID: 30720053", "BibTeX": "@article{30720053, title={Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo}, author={Yang X and Yang T and Li J and Yang R and Qi S and Zhao Y and Li L and Li J and Zhang X and Yang K and Xu Y and Liu C}, journal={Int J Mol Med}, volume={43}, number={4}, pages={1611-1622}}"}}, {"_id": "30035421", "pmid": 30035421, "title": "[Effects of oral hypoglycemic drugs on lithogenic properties of urine in nephrolithiasis patients with concurrent type 2 diabetes].", "journal": "Urologiia", "authors": ["Yarovoi SK", "Kareva EN", "Dzhalilov OV"], "date": "2018-07-01T00:00:00Z", "meta_date_publication": "2018 Jul", "meta_volume": "", "meta_issue": "3", "meta_pages": "63-69", "score": 50057.54, "text_hl": "The control group consisted of @SPECIES_9606 @@@patients@@@ receiving @CHEMICAL_Insulin @CHEMICAL_MESH:D007328 @@@insulin@@@ therapy. RESULTS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ tended to acidify urine, thus producing a negative effect on @CHEMICAL_Uric_Acid @CHEMICAL_MESH:D014527 @@@urate@@@ @<m>DISEASE_Nephrolithiasis</m> @DISEASE_MESH:D053040 @@@nephrolithiasis@@@, which is the most prevalent form of @<m>DISEASE_Nephrolithiasis</m> @DISEASE_MESH:D053040 @@@nephrolithiasis@@@ among @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type II diabetes@@@. ", "citations": {"NLM": "Yarovoi SK, Kareva EN, Dzhalilov OV. [Effects of oral hypoglycemic drugs on lithogenic properties of urine in nephrolithiasis patients with concurrent type 2 diabetes]. Urologiia. 2018 Jul;(3):63-69. PMID: 30035421", "BibTeX": "@article{30035421, title={[Effects of oral hypoglycemic drugs on lithogenic properties of urine in nephrolithiasis patients with concurrent type 2 diabetes].}, author={Yarovoi SK and Kareva EN and Dzhalilov OV}, journal={Urologiia}, number={3}, pages={63-69}}"}}]}